We further demonstrated that the SHP-1–induced suppression of EGFR inactivated the Ras/Erk/GSK3β pathway, thus enhancing understanding of the molecular mechanism of breast cancer progression, given that this pathway is known to be dysregulated in many cancers40–42. Here, PTPN6 is linked to breast cancer.